Percutaneous imaging‐guided biopsies in patients with COVID‐19 positive cancer performed at the peak of the COVID‐19 pandemic

We fully agree with Dr. Kapetanakis et al about the unprecedented nature and uncertainty of the situation regarding the current coronavirus disease (COVID-19) outbreak and the need for lung cancer specialists (and oncology departments in general) to adopt management adjustments for patients with lung cancer.1 We agree with the authors that strategies developed to reduce the potential exposure risk of lung cancer patients (such as postponing...